Alpine Immune Sciences, Inc.
CTLA-4 VARIANT IMMUNOMODULATORY PROTEINS AND USES THEREOF
Last updated:
Abstract:
Provided herein are variant CTLA-4 polypeptides and immunomodulatory proteins and nucleic acids encoding such proteins. The immunomodulatory proteins provide therapeutic utility for a variety of disease applications, including for treatment of autoimmune or inflammatory conditions. Compositions and methods for making and using such proteins are provided.
Status:
Application
Type:
Utility
Filling date:
9 Oct 2018
Issue date:
1 Oct 2020